Spring Creek Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Spring Creek Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-95,000	Closed	-$8.83M	–	917
2021 Q4	$8.83M	Buy	+95,000	New	+$6.26M	0.34%	43

Spring Creek Capital's ARNA Position: Q1 2022 in Review

Spring Creek Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 95,000 shares — an estimated $8.83M sold.

Spring Creek Capital first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $8.83M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Spring Creek Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Spring Creek Capital sold 95,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $8.83M.
Spring Creek Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Spring Creek Capital's Arena Pharmaceuticals Inc position peaked at $8.83M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Spring Creek Capital's 13F filing for Q1 2022, filed 13 May 2022.